- Home
- EAD vs MRK Comparison
EAD vs MRK Comparison
Compare EAD & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EAD | MRK |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.3M | 317.8B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | EAD | MRK |
|---|---|---|
| Price | $5.92 | $148.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 27 |
| Target Price | N/A | ★ $158.44 |
| AVG Volume (30 Days) | 323.7K | ★ 6.0M |
| Earning Date | 01-01-0001 | 10-29-2026 |
| Dividend Yield | ★ 8.91% | 2.27% |
| EPS Growth | N/A | ★ 8.01 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $65,011,000,000.00 |
| Revenue This Year | N/A | $3.12 |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.31 |
| 52 Week Low | $5.86 | $82.01 |
| 52 Week High | $6.97 | $157.00 |
Technical Indicators
Market Signals| Indicator | EAD | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 36.38 | 54.01 |
| Support Level | $5.89 | $145.75 |
| Resistance Level | $6.09 | $154.46 |
| Average True Range (ATR) | 0.07 | 4.33 |
| MACD | 0.01 | 0.40 |
| Stochastic Oscillator | 28.27 | 59.56 |
Price Performance
Historical ComparisonAbout EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. The Fund seeks a high level of current income. Capital appreciation is a secondary objective. The fund has single operating segment.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).